INM vs TXT · rev $4.9M vs P/E 19, rev $7.52B
InMed Pharmaceuticals Inc (INM) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
INM currently screens at market cap $5.2M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the INM and TXT stock pages for the full models.
Not investment advice.